Dubai, UAE – Dubai Investment Company announced the signing of an agreement to acquire an 80% stake in CMC, which owns Clemenceau Medical Center in Dubai Medical City. This is within the framework of the group’s strategy to enhance its investments in the healthcare sector.
According to the company’s disclosure on the Dubai Financial Market, the deal will be conducted through a cashless transaction. Through the acquisition of Dubai Industrial Investment Corporation (DII), a wholly owned subsidiary of Dubai Investment. On the target stake in CMC.
The center is a provider of advanced healthcare services, offering specialized services including advanced robotic surgery. Positron emission tomography (PET), along with a range of advanced medical services.
The disclosure explained that the deal is in line with Dubai’s long-term investment strategy. Aiming to strengthen its investment portfolio in healthcare assets. To support the diversification of the group’s business and expand its presence in growth sectors.
The parties to the deal include Dubai Industrial Investment Company (DII) as the acquiring company. In addition to Khasab Investment Company, which will sell 55% of the shares of Clemenceau Medical Center. Clemenceau Medical Company S.A.E.M.L, which will sell 25% of the shares, bringing the total acquired stake to 80%.
The disclosure indicated that the agreement was signed on July 10, 2026, while the deal is expected to be implemented during the period from July 22 to 31, 2026. This is after completing the necessary procedures and requirements.
